Methylenedioxyallylamphetamine

MDAL
Clinical data
Other names	MDAL; 3,4-Methylenedioxy-N-allylamphetamine
Routes of; administration	Oral
ATC code	None;
Pharmacokinetic data
Duration of action	Unknown
Identifiers
	IUPAC name N-[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl]prop-2-en-1-amine;
CAS Number	74698-45-6 ;
PubChem CID	44719581;
ChemSpider	21106331 ;
UNII	HYC85U2R8Z;
CompTox Dashboard (EPA)	DTXSID40660369 ;
Chemical and physical data
Formula	C13H17NO2
Molar mass	219.284 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=C2C(=CC=C1CC(C)NCC=C)OCO2;
	InChI InChI=1S/C13H17NO2/c1-3-6-14-10(2)7-11-4-5-12-13(8-11)16-9-15-12/h3-5,8,10,14H,1,6-7,9H2,2H3 ; Key:BMKCDDFQEGYEJC-UHFFFAOYSA-N ;
	(what is this?) (verify)

Methylenedioxyallylamphetamine (MDAL or 3,4-methylenedioxy-N-allylamphetamine) is a lesser-known drug.^[1]^[2]^[2] It is the N-allyl derivative of 3,4-methylenedioxyamphetamine (MDA).^[1]^[2]

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDAL's minimum dose as 180 mg orally and its duration as unknown.^[1]^[2] MDAL produces few to no effects on its own, but may enhance the effects of psychedelic drugs like LSD.^[1]

Chemistry

Synthesis

The chemical synthesis of MDAL has been described.^[1]

Society and culture

Legal status

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[3]

References

^ ^a ^b ^c ^d ^e ^f ^g Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. MDAL entry
^ ^a ^b ^c ^d Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.
^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

External links

[PiHKAL-1] ^ ^a ^b ^c ^d ^e ^f ^g Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. MDAL entry

[Shulgin2003-2] Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.

[3] "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

[1]

[2]

[3]